Azra AI

Azra AI, founded in 2022, f. k. a. Invenero Holdings, Inc.

, is located in Franklin, US, and focuses on providing an AI platform for oncology care. The company has made three notable deal to date, with its most recent funding round occurring on April 28, 2026. As of May 2026, John Marshall is the CEO of the company. In April 2026, Azra AI, acquired Thynk Health, LLC.

Azra AI offers a comprehensive platform aimed at streamlining oncology care, utilizing AI to improve patient identification and management throughout treatment. The primary product is an AI-powered system that automates the identification of patients needing care by analyzing pathology and radiology reports in real-time. Developed in collaboration with HCA, the platform caters to hospitals and cancer centers across the United States, enhancing patient experience and promoting health equity. Key features include SmartPath Cancer Registry Automation to eliminate manual data entry and a Patient Journey module that tracks patients from suspicion through survivorship.

Azra AI's solutions are designed for adaptability, integrating seamlessly with existing electronic health record (EHR) systems. Azra AI generates revenue through a subscription-based model aimed at healthcare organizations such as hospitals and cancer treatment centers. Clients subscribe to the AI platform, gaining access to features like real-time patient identification and care coordination. Revenue is derived from B2B transactions, with healthcare providers purchasing licenses tailored to their operational needs.

Each client’s pricing plan reflects the customized nature of the services offered, supporting tangible improvements in efficiency and patient revenue. In April 2026, Azra AI, acquired Thynk Health, LLC. The acquisition may enable Azra AI to add lung cancer screening and incidental findings management to its platform, extending coverage from detection to treatment. The combined solution aims to reduce gaps between imaging and care, improving continuity from diagnosis through treatment.